“Teduglutide can reduce parenteral-support needs in short bowel syndrome.”

Supported with scope

The reviewed evidence supports this exact statement only in the situation described below.

Controlled trials and the Gattex label support this outcome in dependent short-bowel-syndrome populations.

What this answer is based on

This answer uses a study that assigned people to groups by chance and measured a health outcome.

Limits of this answer

Adults and labeled pediatric populations with short bowel syndrome dependent on parenteral support. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.

Topic

What a study measured about people's health, symptoms, or ability to function.